Steven Harasym - Precigen VP Relations
| I5X Stock | EUR 0.85 0.07 8.97% |
Insider
Steven Harasym is VP Relations of Precigen
| Phone | 301 556 9900 |
| Web | https://www.precigen.com |
Precigen Management Efficiency
The company has return on total asset (ROA) of (0.1219) % which means that it has lost $0.1219 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.5132) %, meaning that it generated substantial loss on money invested by shareholders. Precigen's management efficiency ratios could be used to measure how well Precigen manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Marc Vermeire | Sumitomo Chemical | N/A | |
| Keigo Sasaki | Sumitomo Chemical | N/A | |
| Kinya Ito | Sanyo Chemical Industries | N/A | |
| Yuichi Fujii | Sanyo Chemical Industries | N/A | |
| Akinori Higuchi | Sanyo Chemical Industries | 64 | |
| Hiroyuki Susaki | Sanyo Chemical Industries | N/A | |
| Xishuan Yan | China BlueChemical | 63 | |
| Kohei Maeda | Sanyo Chemical Industries | 63 | |
| Keiichi Iwata | Sumitomo Chemical | 65 | |
| Xiaobing Kuang | China BlueChemical | N/A | |
| Masahiro Fukui | Sanyo Chemical Industries | N/A | |
| Hiroyuki Tsuruta | Sanyo Chemical Industries | N/A | |
| Teresa Ely | Sumitomo Chemical | N/A | |
| Bradford Ritchie | Sumitomo Chemical | 55 | |
| Robert Tissue | Sumitomo Chemical | 60 | |
| Jian Song | China BlueChemical | 67 | |
| Keiichi Sakata | Sumitomo Chemical | 63 | |
| Danyl Freeman | Sumitomo Chemical | 53 | |
| Hiroshi Ueda | Sumitomo Chemical | 66 | |
| Hiroshi Niinuma | Sumitomo Chemical | 64 | |
| Takashi Shigemori | Sumitomo Chemical | 64 | |
Management Performance
| Return On Equity | -0.51 | |||
| Return On Asset | -0.12 |
Precigen Leadership Team
Elected by the shareholders, the Precigen's board of directors comprises two types of representatives: Precigen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Precigen. The board's role is to monitor Precigen's management team and ensure that shareholders' interests are well served. Precigen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Precigen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steven Frank, Independent Director | ||
| Jeffrey Kindler, Independent Director | ||
| Rob Russell, VP HR | ||
| Randal Kirk, Chairman of the Board, Chief Executive Officer | ||
| Rick Sterling, Chief Financial Officer | ||
| Cesar Alvarez, Independent Director | ||
| Donald Lehr, Chief Legal Officer | ||
| Vinita Gupta, Independent Director | ||
| Rutul Shah, Chief Officer | ||
| Jeffrey Perez, Senior Vice President — Intellectual Property Affairs | ||
| Randal JD, Ex Chairman | ||
| Helen MPH, CEO Pres | ||
| Steven Harasym, VP Relations | ||
| Fred Hassan, Independent Director | ||
| James Turley, Independent Director | ||
| Helen Sabzevari, President, Chief Executive Officer, President - Precigen, Inc. | ||
| Harry Thomasian, Chief Officer | ||
| Marie Rossi, VP Communications | ||
| Dean Mitchell, Independent Director | ||
| Thomas Reed, Founder, Chief Science Officer | ||
| Robert Shapiro, Lead Independent Director |
Precigen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Precigen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.51 | |||
| Return On Asset | -0.12 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | (0.52) % | |||
| Current Valuation | 326.26 M | |||
| Shares Outstanding | 251.01 M | |||
| Shares Owned By Insiders | 10.09 % | |||
| Shares Owned By Institutions | 55.62 % | |||
| Price To Book | 2.33 X | |||
| Price To Sales | 2.70 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Precigen Stock
When determining whether Precigen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precigen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precigen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precigen Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Precigen Stock please use our How to Invest in Precigen guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .